Table 3.
IC50 of NB cell lines treated with GX 15–070 and doxorubicin
| NB cell lines | IC50 (μM) | IC50 (μM) | IC50 (μM) |
|---|---|---|---|
| Doxa | Doxa + 0,05 μM GX 15–070 | Doxa + 0,5 μM GX 15–070 | |
| SK-N-DZ | 0,110 | 0,002 | 3283a10− 4 |
| IGR-NB8 | 1183 | 0,982 | 8565a10 − 11 |
aDox doxorubicin
IC50 of NB cell lines treated with GX 15–070 and doxorubicin
| NB cell lines | IC50 (μM) | IC50 (μM) | IC50 (μM) |
|---|---|---|---|
| Doxa | Doxa + 0,05 μM GX 15–070 | Doxa + 0,5 μM GX 15–070 | |
| SK-N-DZ | 0,110 | 0,002 | 3283a10− 4 |
| IGR-NB8 | 1183 | 0,982 | 8565a10 − 11 |
aDox doxorubicin